IGF2BP1 restricts the induction of human primordial germ cell fate in an m⁶A-dependent manner

Jin Zhang¹, Yashi Gu², Lingling Tong¹, Boshi Feng¹, Shenghua Dong³, Qizhe Shao², Yanxi Chen¹, Huanchang Tu¹, Ziqi Wang¹, Yueqi Wang¹, Xiang Li¹, Honglin Yu², Ziying Lin⁴, Xueting Wang⁴, Zhenfu Li⁵, Zhipeng Ai⁶, Yangquan Xiang⁶, Zhiwei Jiang⁷, Zixin Jin⁸, Zhengyi Li¹, Yuxin Chen¹, Zuolin Shen⁷, Chenyang Huang⁹, Jianzhao Liu⁹, Jian Liu¹⁰, Pengfei Xu⁸, You Yu⁷, Peng Xia⁴, Hongqing Liang¹¹, Huilin Huang¹², Di Chen¹³

Affiliations

¹ Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
² Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK.
³ State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
⁴ Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang 310058, China.
⁵ Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK.
⁶ Division of Human Reproduction and Developmental Genetics, Women's Hospital, and Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China.
⁷ Department for Cardiology of The Second Affiliated Hospital, Center for Infection Immunity, Cancer of Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
⁸ Center for Genetic Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu 322000, China; Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
⁹ MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
¹⁰ Department for Cardiology of The Second Affiliated Hospital, Center for Infection Immunity, Cancer of Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Zhejiang Key Laboratory of Medical Imaging Artificial Intelligence, Haining, Zhejiang 314400, China.
¹¹ Division of Human Reproduction and Developmental Genetics, Women's Hospital, and Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China; Key Laboratory of Reproductive Genetics (Ministry of Education) and Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China. Electronic address: lianghongqing@zju.edu.cn.
¹² State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China. Electronic address: huanghl1@sysucc.org.cn.
¹³ Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK; Zhejiang Key Laboratory of Medical Imaging Artificial Intelligence, Haining, Zhejiang 314400, China; State Key Laboratory of Biobased Transportation Fuel Technology, Haining, Zhejiang 314400, China; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Electronic address: dichen@intl.zju.edu.cn.

PMID: 40436019
DOI: 10.1016/j.stem.2025.05.001

IGF2BP1 restricts the induction of human primordial germ cell fate in an m⁶A-dependent manner

Jin Zhang et al. Cell Stem Cell. 2025.

. 2025 Jul 3;32(7):1122-1138.e13.

doi: 10.1016/j.stem.2025.05.001. Epub 2025 May 27.

Authors

Affiliations

¹ Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
² Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK.
³ State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
⁴ Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, Zhejiang 310058, China.
⁵ Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK.
⁶ Division of Human Reproduction and Developmental Genetics, Women's Hospital, and Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China.
⁷ Department for Cardiology of The Second Affiliated Hospital, Center for Infection Immunity, Cancer of Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.
⁸ Center for Genetic Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu 322000, China; Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
⁹ MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310058, China.
¹⁰ Department for Cardiology of The Second Affiliated Hospital, Center for Infection Immunity, Cancer of Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Zhejiang Key Laboratory of Medical Imaging Artificial Intelligence, Haining, Zhejiang 314400, China.
¹¹ Division of Human Reproduction and Developmental Genetics, Women's Hospital, and Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China; Key Laboratory of Reproductive Genetics (Ministry of Education) and Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China. Electronic address: lianghongqing@zju.edu.cn.
¹² State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China. Electronic address: huanghl1@sysucc.org.cn.
¹³ Center for Regeneration and Cell Therapy of Zhejiang University, University of Edinburgh Institute (ZJU-UoE Institute), Center for Reproductive Medicine of The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China; Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, the University of Edinburgh, Edinburgh, UK; Zhejiang Key Laboratory of Medical Imaging Artificial Intelligence, Haining, Zhejiang 314400, China; State Key Laboratory of Biobased Transportation Fuel Technology, Haining, Zhejiang 314400, China; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Electronic address: dichen@intl.zju.edu.cn.

PMID: 40436019
DOI: 10.1016/j.stem.2025.05.001

Abstract

Primordial germ cells (PGCs) are specified early during embryogenesis and establish the germ cell lineage for transmitting genetic and epigenetic information from parents to offspring. However, whether N⁶-methyladenosine (m⁶A)-mediated epigenetic regulation is involved in the specification of PGCs remains elusive. In this study, we report that a knockout of m⁶A writers or overexpression of m⁶A erasers leads to an increased percentage of human PGC-like cells (hPGCLCs) induced from embryonic stem cells using a 3D aggregate system. We identify the m⁶A reader IGF2BP1 as the key factor for restricting hPGCLC fate induction by stabilizing OTX2 mRNAs in an m⁶A-dependent manner. In turn, OTX2 protein suppresses the function of TFAP2C via histone variant MacroH2A.1 during germ cell lineage specification. We also observe a similar role of Igf2bp1 in zebrafish in the induction of PGC fate. In summary, we identify an m⁶A-IGF2BP1-OTX2-MacroH2A.1-TFAP2C signaling axis that restricts the specification of human germ cell fate.

Keywords: IGF2BP1; MacroH2A.1; OTX2; PGC restrictors; TFAP2C; m(6)A modification; primordial germ cells.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

IGF2BP1 restricts the induction of human primordial germ cell fate in an m⁶A-dependent manner

Affiliations

IGF2BP1 restricts the induction of human primordial germ cell fate in an m⁶A-dependent manner

Authors

Affiliations

Abstract

Conflict of interest statement

MeSH terms

Substances